DWA
AGTC

Dorsey Wright & Associates’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Dorsey Wright & Associates’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,050
Closed -$12K – 385
2020
Q2 		$12K Buy
+2,050
New +$9.39K ﹤0.01% 212

Other funds holding AGTC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Dorsey Wright & Associates's AGTC Position: Q3 2020 in Review

Dorsey Wright & Associates sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2020, closing a stake of 2,050 shares — an estimated $12K sold.

Dorsey Wright & Associates first reported a position in AGTC in Q2 2020 and held it in 1 quarter. The position peaked at $12K in Q2 2020. 71 funds tracked by Wall St. Rank hold AGTC as of Q3 2020.

  • Dorsey Wright & Associates reported no remaining Applied Genetic Technologies Corporation position as of Q3 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 2,050 Applied Genetic Technologies Corporation shares in Q3 2020, an estimated $12K.
  • Dorsey Wright & Associates first reported a position in Applied Genetic Technologies Corporation in Q2 2020 and held it in 1 quarter.
  • Dorsey Wright & Associates's Applied Genetic Technologies Corporation position peaked at $12K in Q2 2020.
  • 71 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2020.

Based on Dorsey Wright & Associates's 13F filing for Q3 2020, filed 28 Oct 2020.